194 related articles for article (PubMed ID: 18549323)
1. Targeting prion proteins in neurodegenerative disease.
Gilch S; Krammer C; Schätzl HM
Expert Opin Biol Ther; 2008 Jul; 8(7):923-40. PubMed ID: 18549323
[TBL] [Abstract][Full Text] [Related]
2. Therapy in prion diseases: from molecular and cellular biology to therapeutic targets.
Krammer C; Vorberg I; Schätzl HM; Gilch S
Infect Disord Drug Targets; 2009 Feb; 9(1):3-14. PubMed ID: 19200010
[TBL] [Abstract][Full Text] [Related]
3. Prion diseases: from molecular biology to intervention strategies.
Nunziante M; Gilch S; Schätzl HM
Chembiochem; 2003 Dec; 4(12):1268-84. PubMed ID: 14661267
[TBL] [Abstract][Full Text] [Related]
4. Prion diseases and the BSE crisis.
Prusiner SB
Science; 1997 Oct; 278(5336):245-51. PubMed ID: 9323196
[TBL] [Abstract][Full Text] [Related]
5. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
6. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
[TBL] [Abstract][Full Text] [Related]
7. [Prion protein and copper: a mysterious relationship].
Rachidi W; Riondel J; McMahon HM; Favier A
Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
[TBL] [Abstract][Full Text] [Related]
8. Aptamers against prion proteins and prions.
Gilch S; Schätzl HM
Cell Mol Life Sci; 2009 Aug; 66(15):2445-55. PubMed ID: 19396399
[TBL] [Abstract][Full Text] [Related]
9. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
10. Anti-prion antibodies for prophylaxis following prion exposure in mice.
Sigurdsson EM; Sy MS; Li R; Scholtzova H; Kascsak RJ; Kascsak R; Carp R; Meeker HC; Frangione B; Wisniewski T
Neurosci Lett; 2003 Jan; 336(3):185-7. PubMed ID: 12505623
[TBL] [Abstract][Full Text] [Related]
11. Evolving views in prion glycosylation: functional and pathological implications.
Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
[TBL] [Abstract][Full Text] [Related]
12. A transmembrane form of the prion protein in neurodegenerative disease.
Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
14. Update on Creutzfeldt-Jakob disease.
Mallucci G; Collinge J
Curr Opin Neurol; 2004 Dec; 17(6):641-7. PubMed ID: 15542971
[TBL] [Abstract][Full Text] [Related]
15. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic approaches targeting the prion receptor LRP/LR.
Zuber C; Ludewigs H; Weiss S
Vet Microbiol; 2007 Aug; 123(4):387-93. PubMed ID: 17498894
[TBL] [Abstract][Full Text] [Related]
17. Prion channel proteins and their role in vacuolation and neurodegenerative diseases.
Kourie JI
Eur Biophys J; 2002 Sep; 31(5):409-16. PubMed ID: 12202918
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity.
Telling GC; Parchi P; DeArmond SJ; Cortelli P; Montagna P; Gabizon R; Mastrianni J; Lugaresi E; Gambetti P; Prusiner SB
Science; 1996 Dec; 274(5295):2079-82. PubMed ID: 8953038
[TBL] [Abstract][Full Text] [Related]
19. Thienyl pyrimidine derivatives with PrP(Sc) oligomer-inducing activity are a promising tool to study prions.
Imberdis T; Ayrolles-Torro A; Verdier JM; Perrier V
Curr Top Med Chem; 2013; 13(19):2477-83. PubMed ID: 24059332
[TBL] [Abstract][Full Text] [Related]
20. Prion-induced neuronal damage--the mechanisms of neuronal destruction in the subacute spongiform encephalopathies.
Giese A; Kretzschmar HA
Curr Top Microbiol Immunol; 2001; 253():203-17. PubMed ID: 11417136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
